Have a feature idea you'd love to see implemented?
Let us know!
TXMD TherapeuticsMD Inc
Price (delayed)
$1.58
Market cap
$18.22M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.53
Enterprise value
$18.99M
TherapeuticsMD, Inc. is an innovative, leading healthcare company, focused on developing and commercializing novel products exclusively for women. Our products are designed to address the unique changes and challenges women
Highlights
TXMD's quick ratio is up by 39% year-on-year and by 20% since the previous quarter
TXMD's debt is down by 13% year-on-year and by 5% since the previous quarter
The net income has plunged by 114% YoY but it is up by 18% from the previous quarter
The company's EPS has shrunk by 111% YoY but it rose by 22% QoQ
TXMD's revenue has dropped by 99% year-on-year and by 17% since the previous quarter
The gross profit has plunged by 99% YoY and by 17% from the previous quarter
Key stats
What are the main financial stats of TXMD
Market
Valuations
Earnings
Shares outstanding
11.53M
Market cap
$18.22M
Enterprise value
$18.99M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.66
Price to sales (P/S)
18.29
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
19.07
Revenue
$996,000
EBIT
-$6.22M
EBITDA
-$5.14M
Free cash flow
-$9.39M
Per share
Balance sheet
Liquidity
EPS
-$0.53
Free cash flow per share
-$0.81
Book value per share
$2.4
Revenue per share
$0.09
TBVPS
$3.09
Total assets
$40.13M
Total liabilities
$12.46M
Debt
$6M
Equity
$27.67M
Working capital
$6.01M
Debt to equity
0.22
Current ratio
2.03
Quick ratio
1.4
Net debt/EBITDA
-0.15
Margins
Efficiency
Dividend
EBITDA margin
-516%
Gross margin
100%
Net margin
-610.9%
Operating margin
-699.4%
Return on assets
-13.8%
Return on equity
-21.4%
Return on invested capital
-20.6%
Return on capital employed
-18.1%
Return on sales
-624.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
TXMD stock price
How has the TherapeuticsMD stock price performed over time
Intraday
0.32%
1 week
3.44%
1 month
-7.6%
1 year
-30.7%
YTD
-29.78%
QTD
-4.82%
Financial performance
How have TherapeuticsMD's revenue and profit performed over time
Revenue
$996,000
Gross profit
$996,000
Operating income
-$6.97M
Net income
-$6.09M
Gross margin
100%
Net margin
-610.9%
TherapeuticsMD's operating income has shrunk by 124% YoY
The net income has plunged by 114% YoY but it is up by 18% from the previous quarter
TXMD's revenue has dropped by 99% year-on-year and by 17% since the previous quarter
The gross profit has plunged by 99% YoY and by 17% from the previous quarter
Growth
What is TherapeuticsMD's growth rate over time
Valuation
What is TherapeuticsMD stock price valuation
P/E
N/A
P/B
0.66
P/S
18.29
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
19.07
The company's EPS has shrunk by 111% YoY but it rose by 22% QoQ
The stock's price to book (P/B) is 27% less than its last 4 quarters average of 0.9
The equity has contracted by 11% YoY and by 3.5% from the previous quarter
TXMD's revenue has dropped by 99% year-on-year and by 17% since the previous quarter
TXMD's price to sales (P/S) is 76% higher than its 5-year quarterly average of 10.4 and 24% higher than its last 4 quarters average of 14.8
Efficiency
How efficient is TherapeuticsMD business performance
TXMD's return on assets has dropped by 127% year-on-year but it is up by 12% since the previous quarter
TherapeuticsMD's ROE has plunged by 106% YoY but it has increased by 15% from the previous quarter
The ROIC has plunged by 103% YoY but it has increased by 20% from the previous quarter
Dividends
What is TXMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for TXMD.
Financial health
How did TherapeuticsMD financials performed over time
TherapeuticsMD's current ratio has increased by 48% YoY and by 14% from the previous quarter
TXMD's total liabilities is down by 45% year-on-year and by 7% since the previous quarter
TXMD's debt is 78% smaller than its equity
TXMD's debt is down by 13% year-on-year and by 5% since the previous quarter
The equity has contracted by 11% YoY and by 3.5% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.